MY8200214A - Benzo or heretocyclic fused imidazodiazepine and pharmaceutical compositions containing them - Google Patents

Benzo or heretocyclic fused imidazodiazepine and pharmaceutical compositions containing them

Info

Publication number
MY8200214A
MY8200214A MY214/82A MY8200214A MY8200214A MY 8200214 A MY8200214 A MY 8200214A MY 214/82 A MY214/82 A MY 214/82A MY 8200214 A MY8200214 A MY 8200214A MY 8200214 A MY8200214 A MY 8200214A
Authority
MY
Malaysia
Prior art keywords
heretocyclic
imidazodiazepine
benzo
fused
pharmaceutical compositions
Prior art date
Application number
MY214/82A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MY8200214A publication Critical patent/MY8200214A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MY214/82A 1974-09-11 1982-12-30 Benzo or heretocyclic fused imidazodiazepine and pharmaceutical compositions containing them MY8200214A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50492474A 1974-09-11 1974-09-11

Publications (1)

Publication Number Publication Date
MY8200214A true MY8200214A (en) 1982-12-31

Family

ID=24008278

Family Applications (1)

Application Number Title Priority Date Filing Date
MY214/82A MY8200214A (en) 1974-09-11 1982-12-30 Benzo or heretocyclic fused imidazodiazepine and pharmaceutical compositions containing them

Country Status (32)

Country Link
JP (1) JPS51125099A (fr)
AT (1) AT360023B (fr)
AU (1) AU505998B2 (fr)
BE (1) BE833248A (fr)
BR (1) BR7505864A (fr)
CA (1) CA1067491A (fr)
CH (2) CH619953A5 (fr)
CU (1) CU20892L (fr)
DD (1) DD121640A5 (fr)
DE (1) DE2540522A1 (fr)
DK (1) DK157615C (fr)
ES (1) ES440850A1 (fr)
FI (1) FI63234C (fr)
FR (2) FR2285890A1 (fr)
GB (1) GB1527131A (fr)
HK (1) HK63381A (fr)
HU (1) HU174752B (fr)
IE (1) IE41844B1 (fr)
IL (1) IL48069A (fr)
KE (1) KE3173A (fr)
LU (1) LU73356A1 (fr)
MX (1) MX160600A (fr)
MY (1) MY8200214A (fr)
NL (1) NL171060C (fr)
NO (4) NO147109C (fr)
NZ (1) NZ178635A (fr)
PH (2) PH16152A (fr)
PL (1) PL106563B1 (fr)
SE (4) SE425785B (fr)
SU (1) SU814278A3 (fr)
YU (1) YU40267B (fr)
ZA (1) ZA755418B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125726A (en) * 1977-03-11 1978-11-14 Hoffmann-La Roche Inc. Imidazo[1,5-a][1,4]benzodiazepines
US4118386A (en) * 1977-04-04 1978-10-03 Hoffmann-La Roche Inc. Synthesis of imidazo[1,5-a]diazepine-3-carboxylates
US4226768A (en) * 1979-05-29 1980-10-07 Hoffmann-La Roche Inc. Process for the preparation of imidazobenzodiazepines
US4226771A (en) * 1979-07-25 1980-10-07 Hoffmann-La Roche Inc. 1,2,5-Oxadiazino[5,4-a][1,4]benzodiazepine derivatives
US4256637A (en) * 1979-12-20 1981-03-17 Hoffmann-La Roche Inc. Intermediates for the production of imidazobenzodiazepines
FR2479818A1 (en) * 1980-04-03 1981-10-09 Roussel Uclaf 2-Substd. phenyl 7-nitro 3H 1,4-benzodiazepinyl aminoacid derivs. - are anxiolytics, tranquillisers, sedatives and anticonvulsants, prepd. by reacting aminoacid or peptide with benzodiazepin-2-thione
US4335042A (en) * 1980-04-21 1982-06-15 Hoffmann-La Roche Inc. Process to produce imidazobenzodiazepine intermediates
DE3329515C2 (de) * 1983-08-16 1985-11-14 Krohne Meßtechnik GmbH & Co KG, 4100 Duisburg Elektrische Schaltanordnung für einen magnetisch-induktiven Meßwertgeber
ZA845757B (en) * 1983-08-25 1985-04-24 Hoffmann La Roche Benzodiazepine derivatives
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
FI880814A (fi) * 1987-03-10 1988-09-11 Hoffmann La Roche Imidazodiazepin-derivat.
WO1994026723A2 (fr) * 1993-05-14 1994-11-24 Genentech, Inc. INHIBITEURS DE LA ras FARNESYL-TRANSFERASE
IN184976B (fr) * 1996-06-13 2000-10-14 Ranbaxy Lab Ltd
IT1399764B1 (it) * 2010-05-04 2013-05-03 F S I Fabbrica Italiana Sint Procedimento per la sintesi di 4h-imidazo [1,5-a][1,4]benzodiazepine, in particolare di midazolam.
CN103086986B (zh) * 2011-11-01 2015-11-04 上海医药工业研究院 1,4-苯二氮卓-n-亚硝胺类中间体的制备方法及其应用
CN103804384B (zh) * 2014-01-27 2016-01-20 李宏 苯并二氮杂卓类化合物的制备方法
HUE059774T2 (hu) 2016-03-18 2023-01-28 Uwm Res Foundation Inc Kognitív és hangulati szimptómák kezelése neurodegeneratív és neuropszichiátriai betegségekben ALFA5-öt tartalmazó GABAA receptoragonistákkal
CA3033964A1 (fr) 2016-08-16 2018-02-22 Uwm Research Foundation, Inc. Modulateurs du recepteur gaba(a) et procedes de controle de l'hyperreactivite des voies respiratoires et de l'inflammation dans l'asthme
CN111410658B (zh) * 2020-03-30 2021-03-26 江苏恩华药业股份有限公司 咪达唑仑或其药物组合物的杂质a和杂质b及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716775B (en) * 1970-10-30 1972-06-28 Takeda Chemical Industries Ltd Benzodiazepine derivatives
DE2056265A1 (en) * 1970-11-16 1972-05-31 Sumitomo Chemical Co. Ltd., Osaka (Japan) Benzodiazepine derivs - from glycylamidobenzophenone derivs in dmso
JPS4932874B1 (fr) * 1970-12-11 1974-09-03
BE787251A (fr) * 1971-08-04 1973-02-05 Upjohn Co Nouvelles benzodiazepines et leur preparation
BE790839A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles benzodiazepines, leur procede de preparation et medicament les contenant
BE792972A (fr) * 1971-12-20 1973-06-19 Hoffmann La Roche Derives de benzodiazepine
FR2183716A1 (en) * 1972-05-05 1973-12-21 Centre Etd Ind Pharma Substd-6-phenyl-4h-imidazo (1,2-a)-1,4-benzo diazepines - - tranquillisers anxiolytics,sedatives and muscle-relaxants
CA1005443A (en) * 1972-06-22 1977-02-15 Michio Nakanishi Thienodiazepine compounds

Also Published As

Publication number Publication date
ATA697775A (de) 1980-05-15
ES440850A1 (es) 1977-07-01
FI63234B (fi) 1983-01-31
IE41844B1 (en) 1980-04-09
NO147109C (no) 1983-02-02
IE41844L (en) 1976-03-11
JPS51125099A (en) 1976-11-01
SE425785B (sv) 1982-11-08
PH16152A (en) 1983-07-12
DE2540522C2 (fr) 1988-10-20
ZA755418B (en) 1977-06-29
AT360023B (de) 1980-12-10
CH628053A5 (en) 1982-02-15
NZ178635A (en) 1982-12-21
PL106563B1 (pl) 1979-12-31
SE449098B (sv) 1987-04-06
JPS562073B2 (fr) 1981-01-17
CU34346A (es) 1982-08-24
BE833248A (fr) 1976-03-10
FI63234C (fi) 1983-05-10
IL48069A0 (en) 1975-11-25
MX160600A (es) 1993-09-01
NO802719L (no) 1976-03-12
FR2303016B1 (fr) 1982-07-09
DD121640A5 (fr) 1976-08-12
GB1527131A (en) 1978-10-04
SE7902667L (sv) 1979-03-23
AU8470475A (en) 1977-03-17
FR2285890B1 (fr) 1981-12-31
NO147914C (no) 1983-07-06
FR2303016A1 (fr) 1976-10-01
NO147914B (no) 1983-03-28
NL171060C (nl) 1983-02-01
FR2285890A1 (fr) 1976-04-23
YU228575A (en) 1983-01-21
SU814278A3 (ru) 1981-03-15
CH619953A5 (en) 1980-10-31
FI752517A (fr) 1976-03-12
DK157615B (da) 1990-01-29
CA1067491A (fr) 1979-12-04
YU40267B (en) 1985-12-31
NO146573B (no) 1982-07-19
NO148188B (no) 1983-05-16
IL48069A (en) 1980-09-16
DK404175A (da) 1976-03-12
BR7505864A (pt) 1976-08-03
NO148188C (no) 1983-08-24
PH15091A (en) 1982-08-03
CU20892L (es) 1982-08-24
NO802718L (no) 1976-03-12
NO802720L (no) 1976-03-12
LU73356A1 (fr) 1977-05-11
HK63381A (en) 1981-12-24
SE7509991L (sv) 1976-03-12
NO146573C (no) 1982-10-27
SE7902668L (sv) 1979-03-23
SE433080B (sv) 1984-05-07
SE7902666L (sv) 1979-03-23
NO753069L (fr) 1976-03-12
NL7510620A (nl) 1976-03-15
AU505998B2 (en) 1979-12-13
SE440504B (sv) 1985-08-05
KE3173A (en) 1982-01-08
NO147109B (no) 1982-10-25
HU174752B (hu) 1980-03-28
DE2540522A1 (de) 1976-04-08
DK157615C (da) 1990-06-25

Similar Documents

Publication Publication Date Title
MY8200214A (en) Benzo or heretocyclic fused imidazodiazepine and pharmaceutical compositions containing them
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL48209A (en) Amidinourea derivatives and anti-diarrhoeal compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
JPS5384049A (en) Plasticity strengthened composition of polyphenylene eter
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
IL52517A0 (en) New isoxazole derivatives their production and pharmaceutical compositions containing them
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ184981A (en) Thiophene derivatives and pharmaceutical compositions containing them
IL51426A0 (en) Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them
IL53332A0 (en) Morphanthridine derivatives their production and pharmaceutical compositions containing them
IL51572A0 (en) New substituted purines and pharmaceutical compositions containing them
NZ187164A (en) N-phenyl-m-(j-piperidinyl)-amide derivatives and pharmaceutical compositions
NZ184114A (en) Benzo (c) qyinoline derivatives and pharmaceutical compositions
NZ185880A (en) Benzo (b) thiophenses and hypolipaemiant and hypocholesterolaemiant compositions containing them
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
IL53013A0 (en) 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them
JPS549283A (en) Benzoisothiazolone * production thereof and pharmaceutical composition containing same
PH14015A (en) Naphthyridinylisoindolinones and pharmaceucal compositions containing them
PH13885A (en) New perhydroindolinols and pharmaceutical compositions containing them
IL51194A0 (en) Novel ergoline derivatives their production and pharmaceutical compositions containing them